The University of Edinburgh
Cathelicidin as an inducible modulator of respiratory syncytial virus infection
Abstract
dc:description.abstractRespiratory Syncytial Virus (RSV) is a common cause of respiratory tract infections associated with severe disease in infants. The cationic host defence peptide cathelicidin previously demonstrated antiviral activity against RSV in vitro and in vivo, potentially via direct interaction with viral particles. Lower endogenous systemic cathelicidin levels have been linked to RSV severity in infants, while adults with higher nasal cathelicidin resisted RSV challenge. Moreover, tentative links have been made between development of the infant respiratory microbiota and cathelicidin in the context of RSV severity. These results suggest that cathelicidin may modulate RSV susceptibility. However, we are yet to elucidate age, infection, and microbiome-related changes in cathelicidin levels throughout early life and associated value of optimised endogenous cathelicidin induction in protection against severe RSV disease. Through analysis of three longitudinal infant cohorts, this thesis revealed that nasal cathelicidin was detectable after birth, increased rapidly over the first few months of life and during RSV infection and was affected by host and environmental factors including sex and birth season. Characterisation of the infant respiratory microbiota composition before, during and after RSV infection revealed temporal microbiota changes and a potential relationship with nasal cathelicidin. These findings demonstrate influence of environmental factors on early life nasal cathelicidin levels which could impact RSV susceptibility or severity, highlighting potential value of inducing endogenous cathelicidin in at-risk groups. This thesis also characterised genotype-specific differences in immune cell proportions following RSV infection in cell-specific cathelicidin knockout mice. Finally, this thesis found that organic compounds vitamin D3, phenylbutyrate and HO53 induced cathelicidin gene expression and had protective antiviral activity against low level RSV infection in a human epithelial cell line potentially via a mechanism involving type I interferon signalling. The insights gained from this thesis have enhanced understanding of the dynamics of nasal cathelicidin in early life and during initial RSV infection, as well as mechanisms of endogenous peptide induction which may inform development of targeted therapeutic cathelicidin induction approaches or lead to identification of cathelicidin levels as biomarkers of RSV susceptibility or severity.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2022
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Sintoris, Sofia
- Advisors dc:contributor.advisor
-
- Davidson, Donald
- Bogaert, Debby
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/5640